Patent · US Active

Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same

US10071154B2 · kind B2 · utility

2Cited by

69References

16Claims

0Family size

Assignee

The Trustees of the University of Pennsylvania · US

Inventors

David B. Weiner · Yeadon, US
Matthew P. Morrow · Yeadon, US

Key dates

Filing date	Apr 6, 2009
Grant date	Sep 11, 2018
Priority date	—
Expiry date	Aug 10, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions, recombinant vaccines and live attenuated pathogens comprising one or more isolated nucleic acid molecules that encode an immunogen in combination with an isolated nucleic acid molecule that encodes IL-28 or a functional fragment thereof are disclosed. Methods of inducing an immune response in an individual against an immunogen, using such compositions are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.